Overview
Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903
Status:
Completed
Completed
Trial end date:
2020-09-07
2020-09-07
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
A Randomized, Open-label, Oral in healthy male volunteersPhase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Daewon Pharmaceutical Co., Ltd.
Criteria
Inclusion Criteria:- Healthy Volunteers who are ≥19 years old
- BMI between 18 and 30 kg/m2
- Body weight ≥50kg
Exclusion Criteria:
•Clinically significant Medical History